Diagnamed Holdings Corp.
DMED
CNSX
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 671.10K | 274.90K | 331.90K | 373.30K | 475.20K |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 762.30K | 404.90K | 459.20K | 495.70K | 579.30K |
Operating Income | -762.30K | -404.90K | -459.20K | -495.70K | -579.30K |
Income Before Tax | -813.70K | -564.00K | -492.80K | -367.80K | -451.40K |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -0.81 | -0.56 | -0.49 | -0.37 | -0.45 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -813.70K | -564.00K | -492.80K | -367.80K | -451.40K |
EBIT | -762.30K | -404.90K | -459.20K | -495.70K | -579.30K |
EBITDA | -- | -- | -- | -- | -- |
EPS Basic | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 |
Normalized Basic EPS | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS Diluted | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 |
Normalized Diluted EPS | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Basic Shares Outstanding | 343.25M | 323.99M | 320.92M | 320.21M | 320.23M |
Average Diluted Shares Outstanding | 343.25M | 323.99M | 320.92M | 320.21M | 320.23M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |